MRI of Soft-Tissue Tumors: What to Include in the Report
- PMID: 38696323
- DOI: 10.1148/rg.230086
MRI of Soft-Tissue Tumors: What to Include in the Report
Abstract
MRI serves as a critical step in the workup, local staging, and treatment planning of extremity soft-tissue masses. For the radiologist to meaningfully contribute to the management of soft-tissue masses, they need to provide a detailed list of descriptors of the lesion outlined in an organized report. While it is occasionally possible to use MRI to provide a diagnosis for patients with a mass, it is more often used to help with determining the differential diagnosis and planning of biopsies, surgery, radiation treatment, and chemotherapy (when provided). Each descriptor on the list outlined in this article is specifically aimed to assist in one or more facets of the overall approach to soft-tissue masses. This applies to all masses, but in particular sarcomas. Those descriptors are useful to help narrow the differential diagnosis and ensure concordance with a pathologic diagnosis and its accompanying grade assignment of soft-tissue sarcomas. These include a lesion's borders and shape, signal characteristics, and contrast enhancement pattern; the presence of peritumoral edema and peritumoral enhancement; and the presence of lymph nodes. The items most helpful in assisting surgical planning include a lesion's anatomic location, site of origin, size, location relative to a landmark, relationship to adjacent structures, and vascularity including feeding and draining vessels. The authors provide some background information on soft-tissue sarcomas, including their diagnosis and treatment, for the general radiologist and as a refresher for radiologists who are more experienced in tumor imaging. ©RSNA, 2024 See the invited commentary by Murphey in this issue.
Similar articles
-
Surgical considerations when reporting MRI studies of soft tissue sarcoma of the limbs.Skeletal Radiol. 2017 Dec;46(12):1667-1678. doi: 10.1007/s00256-017-2745-z. Epub 2017 Sep 7. Skeletal Radiol. 2017. PMID: 28884363 Review.
-
Pitfalls in soft tissue sarcoma imaging: chronic expanding hematomas.Skeletal Radiol. 2018 Jan;47(1):119-124. doi: 10.1007/s00256-017-2770-y. Epub 2017 Sep 8. Skeletal Radiol. 2018. PMID: 28887645
-
Non Lipomatous Benign Lesions Mimicking Soft-tissue Sarcomas: A Pictorial Essay.In Vivo. 2018 Mar-Apr;32(2):221-229. doi: 10.21873/invivo.11228. In Vivo. 2018. PMID: 29475903 Free PMC article. Review.
-
Soft-tissue masses and masslike conditions: what does CT add to diagnosis and management?AJR Am J Roentgenol. 2010 Jun;194(6):1559-67. doi: 10.2214/AJR.09.3736. AJR Am J Roentgenol. 2010. PMID: 20489097 Free PMC article. Review.
-
[Soft tissue sarcoma: how can posttreatment alterations be distinguished from recurrences?].Radiologe. 2017 Nov;57(11):923-937. doi: 10.1007/s00117-017-0310-3. Radiologe. 2017. PMID: 29038992 Review. German.
Cited by
-
Imaging of Peripheral Intraneural Tumors: A Comprehensive Review for Radiologists.Cancers (Basel). 2025 Jan 13;17(2):246. doi: 10.3390/cancers17020246. Cancers (Basel). 2025. PMID: 39858028 Free PMC article. Review.
-
Whole-tumor histogram analysis of synthetic MRI for the differentiation of benign and malignant soft-tissue tumors: a preliminary study.Eur Radiol. 2025 Jun 26. doi: 10.1007/s00330-025-11770-3. Online ahead of print. Eur Radiol. 2025. PMID: 40569439
-
Principles of Surgical Treatment of Soft Tissue Sarcomas.Cancers (Basel). 2025 Jan 25;17(3):401. doi: 10.3390/cancers17030401. Cancers (Basel). 2025. PMID: 39941773 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical